| Summary | | | | in an effort to create new growth opportunities. |
| Some of the major markets like cardiovascular and | | | | Recent market events show that competition within |
| orthopedic devices have witnessed immense | | | | the neurovascular and neurostimulation device |
| innovation over the last decade in terms of | | | | markets is on the rise. The market is currently |
| procedural ease of use and catering to previously | | | | dominated by traditionally cardiovascular device |
| unmet needs. The advancement in interventional | | | | centric companies like Medtronic, Boston Scientific and |
| cardiology technology and grafting procedures for | | | | St. Jude Medical. A look at the clinical trial scenario for |
| orthopedic applications has already achieved peaks. | | | | neurostimulation devices and neurovascular stents |
| Both these markets are now saturated in terms of | | | | reiterates this fact. The aforesaid companies |
| innovation and will be deemed as mature markets in | | | | together have over fifteen major clinical trials |
| the next five years. Many of the cardiovascular and | | | | underway, investigating neurology devices for various |
| orthopedic firms are now looking towards new areas | | | | indications. |
| in order to sustain or bolster growth. One such | | | | Scope |
| industry where GlobalData expects huge growth and | | | | - The study discusses the neurology devices market, |
| investment opportunities in the future is neurology | | | | presenting the factors that could have a positive |
| devices. | | | | impact on the market. |
| Major cardiovascular technologies such as cardiac | | | | - It provides information on the three key markets |
| rhythm management and stents are now being | | | | – Neurostimulation Devices, Embolic Systems and |
| explored for use in conditions of the nervous system | | | | Neurovascular Stents. |